INHIBITION OF CELL SURVIVAL, TUMOR GROWTH AND HISTONE DEACETYLASE (HDAC) ACTIVITY BY THE DIETARY FLAVONOID LUTEOLIN IN HUMAN EPITHELIOID CANCER CELLS

被引:0
|
作者
Iratni, R.
Attoub, S. [1 ]
Hassan, A. H. [1 ]
Vanhoecke, B. [2 ]
Gaben, A. M. [3 ]
Bracke, M. [4 ]
Al-Sultan, M.
Arafat, K.
Gespach, C. [3 ]
Petroianu, G. [1 ]
机构
[1] UAE Univ, Fac Med & Hlth Sci, Al Ain, U Arab Emirates
[2] Univ Hosp Pintelaan, Lab Expt Canc Res, Ghent, Belgium
[3] Univ Paris 06, INSERM, U673, U938, Paris, France
[4] Univ Hosp Pintelaan, Lab Expt Canc Res, Ghent, Belgium
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S114 / S114
页数:1
相关论文
共 50 条
  • [41] Synergistic Activity of Histone Deacetylase and Proteasome Inhibition Against Pancreatic and Hepatocellular Cancer Cell Lines
    Spratlin, J. L.
    Pitts, T. M.
    Kulikowski, G. N.
    Morelli, M. P.
    Tentler, J. J.
    Serkova, N. J.
    Eckhardt, S. G.
    ANTICANCER RESEARCH, 2011, 31 (04) : 1093 - 1103
  • [42] INHIBITION OF HISTONE DEACETYLASE 6 (HDAC6) PROTECTS AGAINST VINCRISTINE-INDUCED PERIPHERNAL NEUROPATHIES AND INHIBITS TUMOR GROWTH
    Van Helleputte, L.
    Kater, M.
    Cook, D.
    Haeck, W.
    Jaspers, T.
    Geens, N.
    Vanden Berghe, P.
    Geysemans, C.
    Robberecht, W.
    Van Damme, P.
    Cavaletti, G.
    Jarpe, M.
    Van den Bosch, L.
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2017, 22 (03) : 402 - 402
  • [43] Inhibition of histone deacetylase 6 (HDAC6) protects against vincristine-induced peripheral neuropathies and inhibits tumor growth
    Van Helleputte, Lawrence
    Kater, Mandy
    Cook, Dana P.
    Eykens, Caroline
    Rossaert, Elisabeth
    Haeck, Wanda
    Jaspers, Tom
    Geens, Natasja
    Vanden Berghe, Pieter
    Gysemans, Conny
    Mathieu, Chantal
    Robberecht, Wim
    Van Damme, Philip
    Cavaletti, Guido
    Jarpe, Matthew
    Van Den Bosch, Ludo
    NEUROBIOLOGY OF DISEASE, 2018, 111 : 59 - 69
  • [44] Anticancer activity of a novel histone deacetylase inhibitor against human colorectal cancer cells
    Campostrini, N.
    Cecconi, D.
    Mill, A.
    Vindigni, A.
    Bossi, A.
    Righetti, P. G.
    MOLECULAR & CELLULAR PROTEOMICS, 2006, 5 (10) : S97 - S97
  • [45] Inhibition of SRC-3 enhances sensitivity of human cancer cells to histone deacetylase inhibitors
    Zou, Zhengzhi
    Luo, Xiaoyong
    Nie, Peipei
    Wu, Baoyan
    Zhang, Tao
    Wei, Yanchun
    Wang, Wenyi
    Geng, Guojun
    Jiang, Jie
    Mi, Yanjun
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2016, 478 (01) : 227 - 233
  • [46] Anti-tumor activity of a novel histone deacetylase inhibitor, OSU-HDAC42, in oral squamous cell carcinoma
    Weng, Jing-Ru
    Tasi, Chen-Hsun
    Pan, Shiow-Lin
    Guh, Jih-Hwa
    Chiu, Chang-Fang
    Tsai, Ming-Hsui
    CANCER RESEARCH, 2009, 69
  • [47] Class I-Histone Deacetylase (HDAC) Inhibition is Superior to pan-HDAC Inhibition in Modulating Cisplatin Potency in High Grade Serous Ovarian Cancer Cell Lines
    Bandolik, Jan J.
    Hamacher, Alexandra
    Schrenk, Christian
    Weishaupt, Robin
    Kassack, Matthias U.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2019, 20 (12):
  • [48] Low Dosed Interferon Alpha Augments the Anti-Tumor Potential of Histone Deacetylase Inhibition on Prostate Cancer Cell Growth and Invasion
    Hudak, Lukasz
    Tezeeh, Patrick
    Wedel, Steffen
    Makarevic, Jasmina
    Juengel, Eva
    Tsaur, Igor
    Bartsch, Georg
    Wiesner, Christoph
    Haferkamp, Axel
    Blaheta, Roman A.
    PROSTATE, 2012, 72 (16): : 1719 - 1735
  • [49] Pharmacodynamic response and inhibition of growth of human tumor xenografts by the novel histone deacetylase inhibitor PXD101
    Plumb, JA
    Finn, PW
    Williams, RJ
    Bandara, MJ
    Romero, MR
    Watkins, CJ
    La Thangue, NB
    Brown, R
    MOLECULAR CANCER THERAPEUTICS, 2003, 2 (08) : 721 - 728
  • [50] Inhibition of Growth and Induction of Differentiation Markers by Polyphenolic Molecules and Histone Deacetylase Inhibitors in Colon Cancer Cells
    Lea, Michael A.
    Ibeh, Chinwe
    Han, Lydia
    desBordes, Charles
    ANTICANCER RESEARCH, 2010, 30 (02) : 311 - 318